Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020

Keri N Althoff, PhD, MPH, David J Schlueter PhD, Hoda Anton-Culver, PhD, James Cherry, PhD, Joshua C Denny, MD, MS, Isaac Thomsen, MD, MSCI, Elizabeth W Karlson, MD, MS, Fiona P Havers, MD, MHS, Mine S Cicek, PhD, Stephen N Thibodeau, PhD, Ligia A Pinto, PhD, Douglas Lowy, MD, Bradley A Malin, PhD, Lucila Ohno-Machado, MD, PhD, MBA, Carolyn Williams, PhD, MPH, David Goldstein, PhD, Aymone Kouame, MSDA, MSIS, Andrea Ramirez, MD, MS, Adrienne Roman, PhD, Norman E Sharpless, MD, Kelly A Gebo, MD, MPH, Sheri D Schully, PhD, on behalf of the All of Us Research Program,

Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020

Keri N Althoff, PhD, MPH, David J Schlueter, PhD, Hoda Anton-Culver, PhD, James Cherry, PhD, Joshua C Denny, MD, MS, Isaac Thomsen, MD, MSCI, Elizabeth W Karlson, MD, MS, Fiona P Havers, MD, MHS, Mine S Cicek, PhD, Stephen N Thibodeau, PhD, Ligia A Pinto, PhD, Douglas Lowy, MD, Bradley A Malin, PhD, Lucila Ohno-Machado, MD, PhD, MBA, Carolyn Williams, PhD, MPH, David Goldstein, PhD, Aymone Kouame, MSDA, MSIS, Andrea Ramirez, MD, MS, Adrienne Roman, PhD, Norman E Sharpless, MD, Kelly A Gebo, MD, MPH, Sheri D Schully, PhD, on behalf of the All of Us Research Program

Clinical Infectious Diseases. 2021 June 15:ciab519. https://doi.org/10.1093/cid/ciab519